Cleared Traditional

K872044 - CARBON ELECTRODE

K872044 is the FDA 510(k) clearance for CARBON ELECTRODE by Futuremed Div. of Future Impex Corp.. It is a Class 2 Neurology device (product code GXY) cleared through the Traditional 510(k) pathway after a 50-day FDA review.

K872044 · Futuremed Div. of Future Impex Corp. · Neurology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jul 1987
Decision
50d
Days
Class 2
Risk

K872044 is an FDA 510(k) clearance for the CARBON ELECTRODE. Classified as Electrode, Cutaneous (product code GXY), Class II - Special Controls.

Submitted by Futuremed Div. of Future Impex Corp. (Deerpark, US). The FDA issued a Cleared decision on July 16, 1987 after a review of 50 days - a notably fast clearance cycle.

This device falls under the Neurology FDA review panel, regulated under 21 CFR 882.1320 - the FDA neurology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Futuremed Div. of Future Impex Corp. devices

Submission Details

510(k) Number K872044 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received May 27, 1987
Decision Date July 16, 1987
Days to Decision 50 days
Submission Type Traditional
Review Panel Neurology (NE)
Summary -
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
98d faster than avg
Panel avg: 148d · This submission: 50d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code GXY Electrode, Cutaneous
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 882.1320
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Neurology devices follow this clearance model.

Regulatory Peers - GXY Electrode, Cutaneous

All 106
Devices cleared under the same product code (GXY) and FDA review panel - the closest regulatory comparables to K872044.
TENZCARE ELECTRODE 6862
K893793 · 3M Company · Nov 1989
STRAIGHT-LINE FINISH FOR IMPLANTABLE PULSE GENERA.
K881749 · Medtronic Vascular · Jul 1988
MEDTRONIC SNAP EASE MODEL 7795 CUTANEOUS ELECTRODE
K875284 · Medtronic Vascular · Jan 1988
TENZCARE(TM) SNAP ELECTRODE 6867
K864973 · 3M Company · Jan 1987
TENZCARE SNAP ELECTRODE, NO. 6865
K863307 · 3M Company · Sep 1986
POLYHESIVE R ELECTRODES/TENS MUSCLE STIM ELEC THER
K863035 · Valleylab, Inc. · Sep 1986